(Q35013356)

5 August 2017

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms (English)

1 reference

5 August 2017

1 reference

14

Michael A Stoto

1 reference

5 August 2017

9

Mark Munsell

1 reference

5 August 2017

19

Eric J Feuer

1 reference

5 August 2017

2

Kathleen A Cronin

1 reference

5 August 2017

10

Sylvia K Plevritis

1 reference

5 August 2017

1

Jeanne S Mandelblatt

1 reference

5 August 2017

Stephanie Bailey

3

1 reference

5 August 2017

Donald A Berry

4

1 reference

5 August 2017

Harry J de Koning

5

1 reference

5 August 2017

Gerrit Draisma

6

1 reference

5 August 2017

Hui Huang

7

1 reference

5 August 2017

Sandra J Lee

8

1 reference

5 August 2017

Peter Ravdin

11

1 reference

5 August 2017

Clyde B Schechter

12

1 reference

5 August 2017

Bronislava Sigal

13

1 reference

5 August 2017

Natasha K Stout

15

1 reference

5 August 2017

Nicolien T van Ravesteyn

16

1 reference

5 August 2017

John Venier

17

1 reference

5 August 2017

Marvin Zelen

18

1 reference

5 August 2017

Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network

20

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

Annals of Internal Medicine

5 August 2017

1 reference

5 August 2017

151

1 reference

5 August 2017

738-747

1 reference

5 August 2017

10

1 reference

5 August 2017

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Comparing screening mammography for early breast cancer detection in Vermont and Norway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Mammography surveillance and mortality in older breast cancer survivors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

The decrease in breast-cancer incidence in 2003 in the United States

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

A stochastic model for predicting the mortality of breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Performance benchmarks for screening mammography

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Effect of screening and adjuvant therapy on mortality from breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Comparing the performance of mammography screening in the USA and the UK

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Comparison of 1- and 2-year screening intervals for women undergoing screening mammography

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Early detection of disease and scheduling of screening examinations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

American Cancer Society guidelines for breast cancer screening: update 2003.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and Medicine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Flawed inferences about screening mammography's benefit based on observational data

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Quality of life valuations of mammography screening

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Mammography before diagnosis among women age 80 years and older with breast cancer

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Protection of mammography screening against death from breast cancer in women aged 40-64 years

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Retrospective cost-effectiveness analysis of screening mammography.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Efficacy of breast cancer screening in the community according to risk level

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Biennial versus annual mammography and the risk of late-stage breast cancer.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Comparison of screening mammography in the United States and the United kingdom

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Screening for breast cancer

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Ductal Carcinoma in Situ of the Breast

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515682

Hanging in the Balance: Making Decisions About the Benefits and Harms of Breast Cancer Screening Among the Oldest Old Without a Safety Net of Scientific Evidence

9 December 2018

1 reference

12 December 2020

Factors contributing to mammography failure in women aged 40-49 years

1 reference

12 December 2020

In search of the best upper age limit for breast cancer screening

1 reference

12 December 2020

Seventy-five years is an appropriate upper age limit for population-based mammography screening

1 reference

12 December 2020

Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999

1 reference

12 December 2020

Competing risks to breast cancer mortality

1 reference

12 December 2020

Changing patterns in breast cancer incidence trends

1 reference

12 December 2020

The Wisconsin Breast Cancer Epidemiology Simulation Model

1 reference

12 December 2020

Chapter 9: The MISCAN-Fadia Continuous Tumor Growth Model for Breast Cancer

1 reference

12 December 2020

Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis

1 reference

12 December 2020

The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up

1 reference

12 December 2020

Mammography use, breast cancer stage at diagnosis, and survival among older women

1 reference

12 December 2020

Mammography screening among women age 80 years and older: consider the risks

1 reference

12 December 2020

10.7326/0003-4819-151-10-200911170-00010

Identifiers

DOI

1 reference

release_y3oee2v54jc5pea63sbkb774ja

5 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/y3oee2v54jc5pea63sbkb774ja

24 November 2022

mapped directly with Wikidata item

PMCID

3515682

1 reference

5 August 2017

1 reference